A case of Buerger's disease associated with MTHFR C677T mutation homozygosity: A possible therapeutic support

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 14, Issue 4, 2004, Pages 225-226

  Di Micco, P ^a,c   Niglio, A ^a   Scudiero, O ^c   Bonamassa, B ^a   Martinelli, I ^b   Di Fiore, R ^c   Castaldo, G ^d   Salvatore, F ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Hyperhomocysteinemia; MTHFR C677 mutation; Thromboangiitis obliterans

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FOLIC ACID; ILOPROST;

ADULT; ANAMNESIS; BUERGER DISEASE; CASE REPORT; CLINICAL FEATURE; DIET SUPPLEMENTATION; GENE MUTATION; HOMOZYGOSITY; HUMAN; LABORATORY TEST; LETTER; LIMB ISCHEMIA; MALE; TREATMENT OUTCOME;

EID: 7744226591     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(04)80009-7     Document Type: Letter

References (16)

1. Shionoya S (1993) Buerger's disease: diagnosis and management. Cardiovasc Surg 1: 207-214
2. Athanassiou P, Mc Hale J, Dikeou S, Laffan M, Dantis P, Davies KA (1995) Buerger's disease and protein S deficiency: Successful treatment with prostacyclin. Clin Exp Rheumatol 13: 371-375
3. Caramaschi P, Biasi D, Carletto A, Poli G, Bambara LM (1996) A case of Buerger's disease with very high levels of lipoprotein (a). Clin Exp Rheumatol 14: 347-348
4. Biasi D, Caramaschi P, Carletto A, Pasqualini R, Bambara LM (1999) A case of Buerger's disease associated with high levels of lipoprotein (a). Clin Rheumatol 18: 59-60
5. Olin JW, Childs MB, Bartholomew JR, Calabrese HL, Young JR (1996) Anticardiolipin antibodies and homocysteine levels in patients with thromboangiitis obliterans. Arthritis Rheum 39: S47 [abstract]
6. Caramaschi P, Biasi D, Carletto A, et al (2000) Three cases of Buerger's disease associated with hyperhomocysteinemia. Clin Rheumatol 18: 264-265
7. 677T methylenetetrahydrofolate reductase (MTHFR) in Buerger's disease? Thromb Haemost 84: 736-737
8. Griffin JH, Fernàndez JA, Deguchi H (2001) Plasma lipoproteins, haemostasis and thrombosis. Thromb Haemost 86: 386-394
9. Wilson PW, Castelli PW, Kannel WB (1987) Coronary risk prediction in adults (the Framingham study). Am J Cardiol 59: 91G-97G
10. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050
11. Doshi SN, Moat SJ, McDowell IF, Lewis MJ, Goodfellow J (2002) Lowering plasma homocysteine with folk acid in cardiovascular disease: what will the trials tell us? Atherosclerosis 165: 1-3
12. Harker LS, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis. J Clin Invest 58: 731-741
13. Matteucci A, Rossi L, Mariani S, Fagnani F, Quilici S, Cinapri V. Giampietro O (2002) Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Nutr Metab Cardiovasc Dis 12: 184-189
14. Reidy MA (1985) A reassessment of endothelial injury and arterial lesion formation. Lab Invest 53: 513-520
15. Pomerantz KB, Hajjar DP (1989) Eicosanoids in regulation of arterial smooth muscle cell phenotype, proleferative capacity, and cholesterol metabolism. Arteriosclerosis 9: 413-429
16. Ingrosso D, Cimmino A, Perna AF, et al (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361: 1693-1699